Analyzing Clinical Trial Experiences of Prostate Cancer Patients
ConditionProstate Cancer
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexMale
Age18+
SponsorPower Life Sciences Inc.
About this trial
Participation in clinical trials usually favors a particular demographic group. But there is limited research available to explain what trial attributes affect the participation or completion of these specific demographic groups.
This study will admit a wide range of data on the clinical trial experience of Prostate Cancer patients to determine which factors prevail in limiting a patient's ability to join or finish a trial.
It will also try to analyze data from the perspective of different demographic groups to check for recurring trends which might shed insights for the sake of future Prostate Cancer patients.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patient has been diagnosed with Prostate Cancer as identified by imaging
Patient has self-identified as planning to enroll in an interventional clinical trial for Prostate Cancer
Patient is at least 18 years of age
Disqualifiers
Patient does not understand, sign, and return consent form
Inability to perform regular electronic reporting
Patient has a ECOG score of 4
Trial population
Prostate Cancer patients who are actively considering enrolling in an interventional clinical trial to treat their Prostate Cancer, but have yet to complete randomization and enrollment.
Trial design
Design model
Case-crossover
Time perspective
Prospective
Treatments tested in this trial
Not listed
Trial groups
No trial groups listed
Trial outcomes
Primary outcomes
1
Rate of patients who decide to enroll in a Prostate Cancer Clinical Trial
Time frame
3 months2
Number of patients who remain in Prostate Cancer clinical trial until completion of clinical trial
Time frame
12 monthsSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: